Phlow, a Richmond, VA-based pharmaceutical contract growth and manufacturing group (CDMO), raised $37M in Collection C funding.
The spherical was led by Align Non-public Capital LLC, with participation from different undisclosed traders.
The corporate intends to make use of the funds to speed up its enlargement throughout its U.S.-based growth, manufacturing, and digital infrastructure, with a give attention to scaling technology-driven innovation, together with AI-powered techniques and new pharmaceutical manufacturing applied sciences.
Led by Eric S. Edwards, M.D., Ph.D., and CEO and Dave Ryan, CFO, Phlow helps authorities and personal trade clients to create new approaches with scientific experience, manufacturing, and tech-enabled processes that propel the trade ahead to a brand new normal to enhance how medicines are made.
The corporate is quickly increasing its new CDMO companies for pharmaceutical companions, offering superior growth and manufacturing options, comparable to steady circulation chemistry, that assist drive value competitiveness, decrease waste, and enhance environmental outcomes, all whereas enabling accelerated speed-to-marke.
So far, Phlow has raised over $93M in personal capital, alongside greater than $600M in awarded authorities contracts.
FinSMEs
22/07/2025
